A Study to Learn How Different Manufactured Products of the Study Medicine Called Ritlecitinib are Taken up Into the Blood in Healthy Adults When Taken on an Empty Stomach or When Taken With a Meal in Healthy Adults.

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-505603-23-00

Acronym

B7981086

Enrollment

Registered

2023-10-25

Start date

2024-01-29

Completion date

2024-03-28

Last updated

2024-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

alopecia areata, Crohn’s Disease, rheumatoid arthritis, ulcerative colitis, vitiligo

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium

None listed

Source: EU CTIS · Data processed: Feb 4, 2026